Search results
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters via AOL· 6 days ago(Reuters) -The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 6 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 4 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 4 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
FDA approves Moderna’s mRNA RSV vaccine
The Hill via AOL· 6 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 6 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 6 days agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 6 days agoThe U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus vaccine,...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 1 day agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 3 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...